Latest Breaking News On - Bridgewest ventures - Page 1 : comparemela.com

Significant Milestone Reached In First NZ CAR T-cell Trial As Preparations Made For Larger Phase 2 Registration Trial

The goal of CAR T-cell cancer therapy becoming a standard of care in New Zealand is another step closer with patient enrolment completed and a total of 30 patients treated within the Malaghan Institute’s ENABLE phase 1 safety trial, says Malaghan .

New zealand generalNew zealandUnited statesRobert weinkoveAmerican society of hematologyMaurice wilkins centreWellington zhaotai therapiesMalaghan institute clinicalMalaghan institute of medical researchMalaghan instituteHunan zhaotai medical group changshaThompson family foundationMalaghan institute wellingtonHealth research councilZealand ministry of businessSignificant milestone reached in first

Business Scoop » It s Urgent – NZ Biotech s Call To Government

Business Scoop provides news and views on Business and Markets from New Zealand

New zealandJohn robsonZealand biotechnology sectorNational partyPress releaseBridgewest venturesGeneral managerBridgewest ventures newZealand biotechnology sector surveyAusbiotech biotechnology blueprintAustralian biotechnologyZahra championExecutive directorHarnessing biotechNew zealand governmentNew zealand

It s Urgent - NZ Biotech s Call To Government

A comparison between New Zealand and Australia’s approach to biotech shows we're doing a lot of things right, but that government support for the sector in New Zealand could be improved. New Zealand biotech leaders say that if a comprehensive government .

New zealandJohn robsonNational partyZealand biotechnology sectorCall to governmentwednesdayBridgewest venturesGeneral managerBridgewest ventures newZealand biotechnology sector surveyAusbiotech biotechnology blueprintAustralian biotechnologyZahra championExecutive directorHarnessing biotechNew zealand governmentBridgewest ventures nz

BioOra, the Kiwi biotech leading the fight in immune cell cancer therapy

BioOra, the Kiwi biotech leading the fight in immune cell cancer therapy
voxy.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from voxy.co.nz Daily Mail and Mail on Sunday newspapers.

New zealandNew zealandersMalaghan instituteCallaghan innovation technology incubator programmeMedical researchBridgewest venturesCallaghan innovationTechnology incubator

BioOra Appoints Cell Therapy Pioneer, Professor Carl June To Board Of Directors

BioOra , a biopharma joint venture between the Malaghan Institute of Medical Research and Bridgewest Ventures, has appointed Carl June, MD to its Board of Directors. Carl June is globally recognised as a pioneer of CAR (chimeric antigen receptor) T cell .

New zealandNew zealandersRobert weinkovePeter crabtreeMalaghan institute of medical research phaseLaureate in life sciencesMalaghan institutePerelman school of medicineMalaghan institute clinical directorCentre for cellular immunotherapiesAbramson cancer centreUniversity of pennsylvaniaBioora appoints cell therapy pioneerMedical researchBridgewest venturesCarl june